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Interactions characterise the relationship between use of amphetamines, cannabis 
and opiates as a driver and the risk of traffic injury associated with the use of these 
drugs. Inverse risk curves have been found for these drugs, meaning that the higher 
the proportion of drivers in normal traffic testing positive for the drugs, the lower is 
the increase in risk associated with them. The inverse risk curves can arise in many 
ways. The paper discusses ten different interpretations of the curves; seven of these 
are methodological and claim that the risk curves are statistical artefacts. Some 
support for these interpretations is found; however, this does not rule out that 
substantive interpretations, proposing causal mechanisms underlying the curves may 
also be correct. Unfortunately, there is insufficient evidence to assess the support for 
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the substantive interpretations. There is, accordingly, a large element of uncertainty 
about how the inverse risk curves arise and whether they can be modified. 
Key words: illicit drugs; risk of traffic injury; meta-analysis; methodological 
interpretations; substantive interpretations 
 
1 INTRODUCTION 
Many studies have been made to assess the risk of traffic injury associated with the 
use of illicit drugs. For a few drugs, there are enough studies to synthesise their 
findings by means of meta-analysis (Elvik 2013, 2015). Evidence from primary 
studies is then summarised in terms of a single, or a few, summary estimates of the 
risk of injury associated with using a drug. 
One of the problems in trying to synthesise the findings of studies of the risk 
associated with illicit drugs is that estimates vary enormously. When there is great 
variation in estimates of risk, it may not be very informative to summarise them in 
terms of a single weighted mean estimate. In any meta-analysis, it is recommended to 
perform an exploratory analysis in order to test whether the distribution of estimates 
in primary studies is “well-behaved”, i.e. unimodal, showing a bell-shaped 
distribution. A graphical tool, the funnel plot, can be employed to test whether the 
distribution of estimates of risk has this shape. In a funnel plot, estimates of risk are 
plotted on the abscissa and an indicator of their statistical precision on the ordinate.  
Figure 1 presents an example of a funnel plot. It shows estimates of the risk of fatal 
injury associated with the use of amphetamines. The abscissa shows the natural 
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logarithm of the estimate of risk (values greater than 0 indicate an increase in risk), 
the ordinate shows the standard error of each estimate of risk, with the scale inverted 
so that estimates with small standard errors are plotted on top of the diagram. 
Figure 1 about here 
The distribution of estimates of risk in a funnel plot should, ideally speaking, 
resemble a funnel turned upside down (i.e. with the narrow opening on top). The 
data points shown in Figure 1 are spread all over the place and do not show a 
distribution resembling a funnel. Five data points to the right in the diagram are 
trimmed away when the trim-and-fill method is applied to test for the possible 
presence of publication bias (Duval and Tweedie 2000A, 2000B; Duval 2005). Yet, 
even when these data points are trimmed away, no clear funnel shape emerges. Many 
analysts would conclude that the data points in Figure 1 are too widely and 
unsystematically dispersed for a summary estimate of risk to make sense.  
A completely different picture emerges in Figure 2. Figure 2 shows estimates of the 
risk of fatal injury as a function of the percentage of drivers testing positive for 
amphetamine in normal traffic. Figure 2 includes 10 of the 13 estimates shown in 
Figure 1. 
Figure 2 about here 
A clear negative relationship is found: The higher the percentage of drivers testing 
positive for amphetamines in roadside surveys intended to represent normal traffic, 
the lower is the increase in risk associated with the use of amphetamines. Thus, the 
wide and unsystematic dispersion of estimates of risk in Figure 1 hides a very clear 
\\saturn\felles\FILFLYTT\NFR - egenarkivering\Elvik_10.1016_j.aap.2018.02.004.docx 4 
relationship: the lower the share of drivers testing positive for amphetamine, the 
higher is their risk. 
Similar patterns in the variation of risk have been observed for other illicit drugs, 
including cannabis and opiates (Elvik 2015). This suggests that the association 
between the use of an illicit drug and the risk of traffic injury is best summarised by 
means of a function describing the relationship between the share of drivers testing 
positive for a drug in normal traffic and the increase in risk associated with use of the 
drug. Unfortunately, curves like the one shown in Figure 2 can arise in many ways 
and may fully or partly be the result of statistical artefacts. One cannot propose 
substantive explanations of a relationship like the one shown in Figure 2 unless 
methodological interpretations can be ruled out, or at least shown not to contribute 
much to the observed relationship. 
A relationship like the one shown in Figure 2 is referred to as an interaction in 
epidemiology (Szklo and Nieto 2014). An interaction is found whenever the 
relationship between a risk factor (here: an illicit drug) and risk (here: risk of traffic 
injury) depends on a third factor or moderator (here: the share of drivers in normal 
traffic testing positive for a drug). The objectives of this paper are: (1) to give an 
overview of possible interpretations of interaction in estimates of the risk of traffic 
injury associated with the use of illicit drugs and (2) to assess the support for the 
various interpretations. 
 
2 AN OVERVIEW OF INTERPRETATIONS OF INTERACTION 
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A total of ten possible interpretations of interaction effects in estimates of the risk of 
traffic injury associated with the use of illicit drugs have been identified. These are: 
1. Differing statistical weights: A curve based on giving all data points equal 
statistical weights disappears when data points are weighted according to 
their statistical precision. 
2. Unequal variance in exposure estimates: Estimates showing a low percentage 
of control group drivers testing positive may be more uncertain than 
estimates showing a high percentage of control group drivers testing positive. 
3. Selective reporting: Studies reporting the share of control group drivers 
testing positive for a drug differ in estimates of risk from those that do not 
report the share of control group drivers testing positive for a drug. 
4. Unequal adjustment for confounding factors: There may be differences in 
how well estimates of risk adjust for confounding factors; poor control for 
confounding factors tends to be associated with higher estimates of risk. 
5. Different estimators of risk: Odds ratios may overstate relative risks; risk 
estimates based on culpability studies are (almost) consistently erroneous (see 
further explanation below). 
6. Small sample bias in estimates of odds ratios: This could arise if high 
estimates of risk are based on smaller samples than low estimates of risk. 
7. Publication bias: A curve like the one shown in Figure 2 is only one tail of the 
distribution of data points and will vanish when adjusted for publication bias. 
8. Dose-response curve: Some data points could be points on a dose response 
curve: higher doses of a drug may be taken more rarely (lower percentage 
testing positive), but associated with higher risk. 
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9. Learning curve: When a high share of control group drivers test positive for a 
drug, there could be more drivers who have used a drug for a long time and 
developed increased tolerance for it. 
10. Selective recruitment of drivers: In societies where few drive under the 
influence of drugs, those who do so are a more extreme group. 
Table 1 explains how each of these points will be evaluated and what findings will be 
regarded as supporting or contradicting the interpretation. 
Table 1 about here 
The first seven points represent methodological interpretations, i.e. they all claim that 
an apparent interaction is an artefact and will disappear once one or more of the 
seven points have been addressed. The final three points represent substantive 
interpretations, i.e. they identify causal mechanisms that produce an interaction and 
show that it is real. 
The ten possible interpretations of interaction in estimates of risk will be discussed 
for three illicit drugs for which there are enough studies to show interaction. These 
drugs are amphetamines, cannabis and opiates. Patterns of interaction will be 
discussed separately for fatal injury, non-fatal injury and property-damage-only. Five 
estimates of risk are regarded as the minimum number needed to detect interaction. 
Thus, in Figure 2, ten estimates of the risk of fatal injury are plotted for 
amphetamines. There are four estimates of the risk of non-fatal injury associated with 
the use of amphetamines, but these will not be discussed further, because they are 
too few to meaningfully assess the ten possible interpretations of interaction. 
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3 METHODOLOGICAL INTERPRETATIONS 
3.1 Statistical weighting 
The curve shown in Figure 2 was fitted by treating all estimates of risk as equally 
precise. However, the precision of the estimates varies. Will the inverse relationship 
be reproduced if estimates of risk are assigned statistical weights that are inversely 
proportional to their sampling variance? 
To test the robustness of curves with respect to statistical weighting, six different 
forms of curves have been fitted: linear, logarithmic, inverse, quadratic, power or 
exponential. If the curve fitted to weighted estimates is of a different form than the 
curve fitted to unweighted estimates, it will be concluded that the statistical weights 
make a difference. Likewise, if the coefficient describing the slope or curvature of a 
function is statistically significantly different for the simple and weighted estimates, 
statistical weighting makes a difference. 
Curves were fitted using SPSS and for each coefficient a standard error was 
produced. To test whether two coefficients were different, the difference between 
them and the standard error of the difference were computed: 
Difference = 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 −  𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝑤𝑤𝑠𝑠𝑠𝑠𝑤𝑤ℎ𝑡𝑡𝑠𝑠𝑡𝑡 
Standard error (SE) of difference = �𝑆𝑆𝑆𝑆𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠2 + 𝑆𝑆𝑆𝑆𝑤𝑤𝑠𝑠𝑠𝑠𝑤𝑤ℎ𝑡𝑡𝑠𝑠𝑡𝑡2  
As an example, an inverse function best fitted crude estimates of the risk of non-fatal 
injury associated with the use of cannabis. When data points were weighted 
statistically, the value of the coefficient changed a little. The difference is 0.029. The 
standard error of the difference is 0.186. Since the standard error of the difference is 
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considerably greater than the difference itself, it is concluded that there is no 
evidence of a real difference. The results of the analyses are presented in Table 2.  
Table 2 about here 
It is seen that the number of estimates of risk is by far greatest for cannabis. 
Statistical weighting was found to influence the risk curves in three of the six cases 
that were tested. For amphetamines, the crude risk curve was best described as a 
power function; the statistically weighted risk curve was best described as an inverse 
function. A plot of the functions found that they were located close to each other 
and had the same shape. With respect to the risk of fatal injury associated with the 
use of cannabis, a logarithmic function fitted best to the crude estimates of risk. A 
quadratic function fitted best to the weighted estimates. Since these functions are of 
different forms, comparing their coefficients does not make sense. The two curves 
are shown in Figure 3. The quadratic curve is quite flat in the range below 10 percent 
of control group drivers testing positive for cannabis. The quadratic curve implies a 
negative estimate of risk when the percentage of control group drivers testing 
positive for cannabis exceeds 40 percent, but is positive in the range of values 
represented in the data.  
Figure 3 about here 
The third case where the crude and weighted curves were found to differ was with 
respect to the risk of non-fatal injury associated with the use opiates. The curve 
fitting best to the weighted data points was quadratic; however, it was rejected as it 
implied negative estimates of risk when the percentage of control group drivers 
testing positive for opiates was between 5.6 and 7.4. A linear function fitted second 
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best and was preferred. Figure 4 shows the two curves that were found to best fit 
estimates of risk. 
Figure 4 about here 
The two curves are quite different. Although both are consistent with an inverse 
relationship between the prevalence of opiates in normal traffic and the risk 
associated with it, the weighted curve is a straight line, whereas the crude curve has a 
marked curvature. 
 
3.2 Unequal uncertainties in estimates of exposure 
Exposure to illicit drugs in normal traffic is generally stated as the proportion of 
control group drivers testing positive for a drug. Thus, for amphetamines (Figure 2), 
the proportion of control group drivers testing positive varies between 0.05 percent 
(0.0005 as a proportion) and 3.3 percent (0.033 as a proportion). Estimates of the 
proportion of control group drivers testing positive are uncertain. The question is 
whether some of the estimates are more uncertain than others. If, for example, an 
estimated proportion of 0.0005 is more uncertain than an estimated proportion of 
0.033, the distribution of data points could in principle be different from the one 
shown in Figure 2, and the curve fitted to the data points might have a different 
shape. 
The uncertainty of estimates is indicated by their standard error. The standard error 
of a proportion p is: 
Standard error of a proportion = �𝑠𝑠 ∙ (1−𝑠𝑠)
𝑛𝑛
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Thus, the standard error of the smallest of the proportions of control group drivers 
testing positive for amphetamines is: 
Standard error = �0.0005 ∙ (1−0.0005)
21917
= 0.00015 
In general, the standard error of a proportion, at a given sample size (n) is smallest 
when the proportion is close to zero, and greatest when it is 0.5. The standard errors 
of the proportions of control group drivers testing positive for amphetamines are 
small. Figure 5 shows the relationship between the proportions and their standard 
errors. 
Figure 5 about here 
With one exception, the standard errors all have a smaller value than the estimated 
proportion. For one estimate, the standard error is 1.42 times the estimate. There is a 
probability of 5 percent that this estimate, 0.0012, could be as high as 0.0046. 
However, even if the true location of the data point would be at a proportion of 
0.0046, this would by itself not alter the shape of the curve shown in Figure 2.  
As far as cannabis is concerned, a similar pattern was found. On the average, 
standard errors were much smaller than estimated proportions. Only two standard 
errors (out of 63) were larger than 50 percent of the estimate, suggesting that these 
estimates were not significantly different from zero. These two estimates are, 
however, too few to alter the shape of the risk curves relating risk to the proportion 
of control group drivers testing positive for cannabis. 
Findings for opiates were more complex. There were seven estimates of the risk of 
fatal injury for which the proportion of control group drivers testing positive for 
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opiates was known. One estimate of the proportion of control group drivers testing 
positive had a considerably greater standard error than the other six. This estimate 
indicated that only 0.25 percent of control group drivers tested positive and that the 
odds of fatal injury was 9.6. Given the standard error, and assuming that the 
proportion cannot be negative, the lower 95 percent confidence limit for this 
estimate is 0.01 percent and the upper 95 percent confidence limit is 0.73 percent. 
When the lower limit was assumed, the best fitting risk curve was an inverse 
function, which fitted the data much better than when the original value of 0.25 
percent was used. When the upper limit value was assumed, the risk curve changed 
completely and a power function with a positive exponent best fitted the data points. 
Thus, the large uncertainty in the estimate of the proportion of control group drivers 
testing positive for opiates had a decisive influence on the shape of the risk curve 
relating the risk of fatal injury to the proportion of control group drivers testing 
positive for opiates. One should therefore regard the risk curve as highly uncertain 
and perhaps artefactual. 
There were eight estimates of the risk of non-fatal injury for which the percentage of 
control group drivers testing positive for opiates was known. Three of these 
estimates had large standard errors. By inserting the lower or upper 95 percent 
confidence limits of these estimates, the risk curve was re-estimated. The shape of 
the curve was found to be robust with respect to the three uncertain data points. A 
quadratic function fitted best in all cases, but it was mostly illogical by implying 
negative estimates of risk. A linear function was second best. 
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3.3 Selective reporting 
In Figure 1, thirteen estimates of the risk of fatal injury associated with the use of 
amphetamines were shown. In Figure 2, the risk curve was fitted to only ten 
estimates of risk. Three estimates did not report the percentage of control group 
drivers testing positive for amphetamines and could therefore not be included. Even 
among cases, reporting of drug use is incomplete and variable, see for example the 
survey of drug involvement in fatally injured drivers reported by the National 
Highway Traffic Administration (US Department of Transportation 2010). Is it 
possible that these three data points could alter the risk curve shown in Figure 2 
(whose shape was confirmed when data points were weighted)? 
To try to answer this question, a procedure that may be called “worst case 
imputation” has been used. Worst case imputation means that the estimates of risk 
not stating the percentage of control group drivers testing positive for amphetamines 
were added to those stating this percentage in the way that would be most 
inconsistent with the distribution of the estimates stating the percentage of control 
group drivers who tested positive for amphetamines. 
The three estimates not stating the percentage of control group drivers testing 
positive for amphetamines estimated the odds ratio for fatal injury as 20.9, 2.7 and 
2.3. Based on the data points stating the percentage of control group drivers testing 
positive for amphetamines, one would expect the first of these estimates to be 
located in the left part of the diagram, in which the percentage of control group 
drivers testing positive is low. The other two estimates would be expected to be 
located further to the right in the diagram. The assumption was therefore made that, 
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unlike most other data points, for the three data points that did not report the 
percentage of control group drivers testing positive for amphetamines, there was a 
positive relationship between risk and the percentage of control group drivers testing 
positive. 
The three highest values found in the data set for the percentage of control group 
drivers testing positive for amphetamines were 3.30, 3.11 and 0.78. The three 
estimates of risk were therefore imputed as (20.9; 3.30), (2.7; 3.11), and (2.3; 0.78). 
These data points are marked by red squares in Figure 6. 
Figure 6 about here 
One may obviously not rule out that the estimates not reporting the percentage of 
control group drivers testing positive for amphetamines could have reported higher 
percentages than any found in the studies reporting the percentage of control group 
drivers testing positive for amphetamines. The data points should then have been 
imputed even further to the right in the diagram, but it was judged as too arbitrary to 
do so. The three percentages at which the estimates were imputed were at least found 
in the data set. 
With the three imputed estimates added to the data set, the curve fitting routine was 
run again. An inverse function was found to best fit the data points, reproducing the 
result based on the ten original data points. Based on this, selective reporting was 
judged to be unlikely to have an influence on the risk curve for fatal injury associated 
with the use of amphetamines. 
Four data points were imputed for studies of the risk of fatal injury associated with 
the use of cannabis. When these data points were added, the relationship between the 
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percentage of control group drivers testing positive for cannabis and the risk of fatal 
injury vanished completely. With respect to the risk of fatal injury associated with the 
use of cannabis, one therefore cannot rule out bias due to the fact that not all studies 
reported the percentage of control group drivers testing positive for cannabis. No 
missing data points were imputed for studies of the risk of non-fatal injury associated 
with the use of cannabis. Five data points were imputed for studies of the risk of 
property-damage-only accidents. A quadratic curve was found to best fit the imputed 
data set, indicating a high risk when a low percentage of control group drivers test 
positive for cannabis as well as when a high percentage of control group drivers test 
positive for cannabis. It is difficult to make sense of this relationship, but it had the 
same form as the relationship fitted to the original data set. 
There were seven estimates of the risk of fatal injury associated with the use of 
opiates that reported the percentage of control group drivers testing positive for 
opiates; three estimates did not report the percentage of control group drivers testing 
positive. When these estimates were imputed, a power function best fitted as a risk 
curve. This function was rising as the percentage of control group drivers testing 
positive for opiates increased. This risk curve had the opposite sign of the risk curve 
fitted to the original data points, which indicated a declining risk as the percentage of 
control group drivers testing positive for opiates increased. It therefore cannot be 
ruled out that the negative relationship was attributable to the fact that not all studies 
reported the percentage of control group drivers testing positive for opiates. 
Eight estimates of the risk of non-fatal injury associated with the use of opiates 
stated the percentage of control group drivers testing positive for opiates; twelve 
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estimates of risk did not state this percentage. Eight data points were imputed using 
the worst-case rule. The original relationship then vanished completely, showing that 
it cannot be ruled out that the negative relationship found between the percentage of 
control group drivers testing positive for opiates and the risk of non-fatal injury 
associated with the use of opiates, was attributable to the fact that many studies do 
not report the percentage of control group drivers testing positive for opiates. 
 
3.4 Unequal adjustment for potential confounding factors 
It is well known that the results of studies evaluating a certain risk factor are often 
greatly influenced by how well the study controls for other risk factors (Elvik 2011). 
Risk factors tend to be correlated. A study that examines only the simple bivariate 
relationship between a risk factor and the level of risk is therefore likely to 
overestimate the contribution of the risk factor. Numerous studies have found that 
when potentially confounding factors are controlled for, estimates of risk are usually 
adjusted downwards. Table 3 gives some examples of this. 
Table 3 about here 
The examples given in Table 3 all show that adjusted estimates of risk are lower than 
crude estimates, often by 40-50 percent. One can find examples of the opposite 
tendency, but they are far fewer than the examples of studies finding that adjusting 
for potentially confounding factors reduces estimates of risk. In principle, therefore, 
the risk curves found for illicit drugs could be the result of unequal adjustment for 
confounding factors. In particular, the highest estimates of risk might be the least 
well-controlled.  
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To test whether this is the case, estimates of risk were sorted according to the 
number of confounding factors controlled for in estimation. For amphetamines, for 
example, estimates of the risk of fatal injury were available that had controlled for 0, 
1, 2, 4 or 6 confounding factors. The weighted (fixed-effects model) mean estimate 
of risk for each number of confounding factors controlled for was estimated. Curves 
were then fitted to the data points in order to assess whether there was a relationship 
between how well studies controlled for confounding factors and estimates of risk. 
Estimates of the risk of fatal injury associated with the use of amphetamines were 
weakly positively related to the number of confounding factors controlled for, i.e. 
estimates of risk tended to be higher the more confounding factors studies controlled 
for. However, the best fitting curve, an exponential function, explained only 23.4 
percent of the variance and there were only five data points. 
For cannabis, estimates of the risk of fatal injury were found to depend weakly on 
the number of confounding factors controlled for. The summary estimate of risk was 
reduced from 1.82 when 0 confounding factors were controlled for to 1.21 when 6 
confounding factors were controlled for, and increased to 1.29 when 8 confounding 
factors were controlled for. The summary estimate of the risk of non-fatal injury 
declined monotonically from 1.86 when 0 confounding factors were controlled for to 
1.24 when 11 confounding factors were controlled for. For property-damage-only 
accidents a quadratic relationship was again found, with the summary estimate of risk 
first declining as more confounding factors were controlled for, then increasing 
again, but not to the same level as when no confounding factors were controlled for. 
These results suggest that there is a tendency for summary estimates of risk to 
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become lower as more confounding factors are controlled for. The data underlying 
the estimated relationships are, however, very noisy and the results are not 
sufficiently clear to undermine the negative relationship between the share of control 
group drivers testing positive for cannabis and the risk associated with the use of 
cannabis. 
There were few estimates of risk for opiates, but an attempt was nevertheless made 
to determine if there was a relationship between how well studies controlled for 
confounding factors and estimates of risk. A quadratic relationship was found 
between the number of confounding factors controlled for and estimates of the risk 
of fatal injury. The relationship was nonsensical, as it predicted negative estimates of 
risk when seven or more confounding factors were controlled for. Other functions 
fitted to the data (linear and exponential) indicated no relationship between the 
number of confounding factors controlled for and the estimate of risk. For non-fatal 
injury, a very clear negative relationship was found between the number of 
confounding factors controlled for and estimates of risk. Thus, the crude risk curve, 
showing a negative relationship between the percentage of control group drivers 
testing positive for opiates and the increase in risk associated with the use of opiates, 
would vanish completely if all studies had controlled as well for confounding factors 
as the best studies did. 
 
3.5 Choice of estimator of risk 
By far the two most common estimators of risk used in studies of the risk associated 
with the use of drugs is the odds ratio based on case-control studies, and the odds 
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ratio based on culpability studies. A few registry-based studies use standardised 
incidence ratio, which is the incidence of accidents in a population of users of a drug 
(often prescribed) divided by the incidence of accidents in a control population, 
adjusted for age and gender and possibly other confounding factors. 
Røgeberg and Elvik (2016) point out that the odds ratio based on culpability studies, 
as estimated in virtually all studies relying on this approach, does not show the odds 
ratio of accident involvement, but rather the odds ratio of being culpable in an 
accident. The difference between the two can be shown as follows: 





Culpable drivers are those who are held guilty or responsible for an accident, 
nonculpable drivers are those who are innocently involved in accidents and who are 
generally assumed to be representative of normal traffic. Subscript + denotes testing 
positive for a drug, subscript – denotes testing negative for a drug. Culpability studies 
in general estimate the odds ratio of being culpable. However, the odds ratio of 
becoming involved in an accident is: 





As can be seen, the odds ratio of accident involvement will be lower than the odds 
ratio of being culpable, since accident involvement includes involvement both as the 
culpable driver and as the nonculpable driver. How large the difference between the 
two estimators is depends on the share of accidents involving nonculpable drivers. 
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As an example, consider data presented by Terhune (1992) concerning culpability 
and use of drugs. Thus, for amphetamines: Culpable and positive: 10; Nonculpable 
and positive: 2; Culpable and negative: 541; Nonculpable and negative: 258. The 
odds of being culpable (the usual estimator in culpability studies) is: 
(10/541)/(2/258) = 2.38. The odds of accident involvement is: (12/799)/(2/258) = 
1.94. 
To the extent that the highest estimates of risk are based on culpability studies, they 
may be inflated and therefore to some extent explain the negative relationship 
between the percentage of control group drivers testing positive for a drug and the 
risk associated with the drug. For amphetamines, all the highest estimates of risk 
were based on case-control studies, not culpability studies. One can therefore rule 
out that the inverse risk curve was generated by inflated estimates of risk based on 
culpability studies. 
A majority (20 out of 27) of the estimates of the risk of fatal injury associated with 
the use of cannabis were based on culpability studies. Risk curves fitted to estimates 
based on culpability studies and estimates based on case-control studies were similar, 
suggesting that the risk curve is unlikely to be an artefact of inflated estimates of risk 
in culpability studies. For non-fatal injury and property-damage-only, too few 
estimates of the risk associated with the use of cannabis were based on culpability 
studies to make a comparison with case-control studies meaningful. 
Four of seven estimates of the risk of fatal injury associated with the use of opiates 
were based on culpability studies. However, these four estimates were the lowest and 
could therefore not have generated the negative relationship between the percentage 
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of control group drivers testing positive for opiates and the risk of fatal injury 
associated with the use of opiates. No estimate of the risk of non-fatal injury 
associated with the use of opiates was based on a culpability study. 
 
3.6 Small sample bias in estimates of odds ratios 
When the odds ratio of injury associated with the use of a drug is estimated by means 
of a maximum-likelihood logistic regression model, it will have an upward bias in 
small samples (Greenland 2000, Nemes et al. 2009). The size of the bias can be 
substantial. This is a potential source of error if the highest estimates of risk 
underlying the risk curves were based on logistic regression models fitted to small 
samples. The analysis in this paper does not aim to correct any bias, merely assess 
whether it is a potential source of error in the risk curves. 
To probe whether small sample bias in logistic regression models could be a source 
of error in the estimated risk curves, the statistical weights assigned to studies using 
logistic regression were compared to the statistical weights of studies not using 
logistic regression. Fixed-effects statistical weights indicate sample size. If the highest 
estimates of risk, associated with a low percentage of control group drivers testing 
positive for a drug, are based on logistic regression models developed in small 
samples (small statistical weights), the resulting risk curves could be partly artefactual. 
For each study, it was noted whether statistical analysis was based on logistic 
regression. It was found that logistic regression models are very widely used to 
estimate odds ratios that control for various confounding factors. For amphetamines, 
three of the high estimates of the risk of fatal injury were based on logistic 
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regression. However, when these were removed, the remaining estimates still 
indicated an inverse risk curve, i.e. a curve showing the lowest risk for the highest 
percentage of control group drivers testing positive for amphetamines. Such a risk 
curve would emerge even if the estimates based on logistic regression were retained, 
but arbitrarily divided by 2 to adjust for a potential bias. 
A similar assessment was made for studies of the risk associated with cannabis. For 
fatal injury, a negative risk curve remained both when four high estimates of risk 
based on logistic regression were deleted and when the estimates of risk were divided 
by two. Biased estimates of risk do therefore not seem to explain the negative risk 
curve with respect to fatal injury. With respect to non-fatal injury, the inverse risk 
curve disappeared when five high estimates of risk based on logistic regression were 
removed, but re-appeared when these estimates were included but divided by two. 
This result is somewhat ambiguous, but suggests that it cannot be ruled out that the 
risk curve for non-fatal injury is to some extent influenced by biased estimates of risk 
based on logistic regression. As far as property damage is concerned, removing 
potentially biased estimates of risk did not change the relationship to the percentage 
of control group drivers testing positive for cannabis, which remained quadratic. 
For opiates, there were no high estimates if the risk of fatal injury based on logistic 
regression. There were two high estimates of the risk of non-fatal injury based on 
logistic regression; however, removing these or dividing them by two did not change 
the inverse risk curve. 
 
3.7 Publication bias 
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To assess the possible presence of publication bias, the trim-and-fill technique was 
applied (Duval and Tweedie 2000A, 2000B, Duval 2005). As already noted, five data 
points were trimmed away in studies of the risk of fatal injury associated with 
amphetamines. For four of these data points, the percentage of control group drivers 
testing positive for amphetamines was reported. When these four data points were 
filled in, to represent non-published results, an inverse risk curve was still found. 
Thus, publication bias does not explain the inverse risk curve for the risk of fatal 
injury associated with amphetamines. 
For cannabis, an analysis adding two missing data points for fatal injury reproduced a 
quadratic function, suggesting that publication bias did not influence the form of the 
relationship between the percentage of control group drivers testing positive for 
cannabis and the risk of fatal injury associated with the use of cannabis. The risk 
curve for non-fatal injury associated with the use of cannabis, adjusted for 
publication bias, was an inverse function. This is the same functional form as found 
without adjusting for publication bias. The risk of property-damage-only, adjusted 
for publication bias, was a quadratic function of the percentage of control group 
drivers testing positive for cannabis. This functional form was the same as found 
without adjusting for publication bias. On the whole, publication bias does not 
appear to influence the risk curves for cannabis very much. 
The risk of fatal injury associated with opiates, adjusted for publication bias, was best 
described as an exponential function of the share of control group drivers testing 
positive for opiates. Estimated risk was increasing as a function of the percentage of 
control group drivers testing positive for opiates. This risk curve was very unlike the 
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inverse function found when publication bias was not considered. It may therefore 
not be ruled out that the inverse function originally found can be influenced by 
publication bias. The risk of non-fatal injury associated with the use of opiates, 
adjusted for publication bias, was best described as a quadratic function of the 
percentage of control group drivers testing positive for opiates. This function was 
not the same as found without considering publication bias, again suggesting that it 
may have influenced the risk curve found initially. 
 
4 SUBSTANTIVE INTERPRETATIONS 
4.1 Dose-response curve 
An inverse function relating the risk of injury associated with a drug to the frequency 
of use of drug in normal traffic can, at least in part be a dose-response curve. It 
could, for example, be the case that low doses, associated with small increases in risk, 
are taken frequently and higher doses, associated with larger increases in risk, are 
taken more rarely. If the percentage of control group drivers testing positive for a 
drug indicates the frequency of use, an inverse risk curve could be a dose-response 
curve. 
Unfortunately, few studies of the risk associated with illicit drugs have tried to 
estimate a dose-response relationship. For amphetamines and opiates, no study has 
been found reporting a dose-response relationship between the dose taken of the 
drug and the increase in accident risk. For cannabis, a few studies have compared 
risks associated with different doses of the drug. Based on these studies, an attempt 
has been made to test whether an inverse risk curve for cannabis can arise as a result 
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of a dose-response relationship. Since the dose taken was not coded the same way in 
all studies, it was categorised as low, medium and high. 
In the study by Mann et al. (2007), use of cannabis at least once during lifetime was 
coded as “low”, and use within the last hour as “high”. In the study by Fergusson et 
al. (2008), self-reported cases of driving under the influence of cannabis 1-10 times 
per year was coded as “low”, 11-20 times per year as “medium” and 21 times or 
more per year coded as “high”. In the study by Pulido et al. (2010) weekly use of 
cannabis was rated as “low”, use 1-4 times per week as “medium” and use more than 
4 times per week as “high”. Gadegbeku et al. (2011) specified the concentration of 
tetra-hydro-cannabinol (THC) in blood as 1-3 ng/ml (“low”), 3-5 ng/ml (“medium”) 
or ≥ 5 ng/ml (“high”). A similar scale was used by Poulsen et al. (2014), with 
intervals given as < 2 ng/ml (“low”), 2-5 ng/ml (“medium”) or > 5 ng/ml (“high”). 
Using these codes, the curves shown in Figure 7 emerge. 
Figure 7 about here 
There were five estimates of risk at a high dose, four at a medium dose and five at a 
low dose. At high or medium doses, risk is found to decrease as the percentage of 
control group drivers testing positive for cannabis increases. At low doses, no such 
tendency can be found. When all data points are considered as a whole, there is a 
clear negative relationship between the percentage of control group drivers testing 
positive for cannabis and the risk associated with the use of cannabis. Hence, an 
inverse risk curve may, at least to some extent, be the result of a dose-response 
relationship. 
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4.2 Learning curve 
An inverse risk curve could be a learning curve, if those who are located to the left 
are inexperienced and do not tolerate a drug very well, whereas those to the right 
have a long history of using a drug, tolerate it well and therefore are less at risk when 
taking the drug than less experienced users. To evaluate this hypothesis, one needs to 
know whether high-risk users of a drug are novice users of it and low-risk users of a 
drug are seasoned users of it. 
Unfortunately, data of this kind are completely absent from studies of the risk 
associated with drug use. These studies are almost exclusively case-control studies or 
culpability studies. Both these study designs are cross-sectional, i.e. they compare 
different individuals at a given point in time and do not follow the same individuals 
over time. Thus, if a group is identified in a case-control study as having a particularly 
high risk, it will consist of different individuals than a group identified in the same 
case-control study as having low risk. Even if drug use history was known for both 
groups, one cannot know whether the difference in risk was caused by differences in 
drug use history or another factor, since it is impossible to control for all factors that 
may explain differences in risk. Indeed, most case-control studies control for just a 
few confounding factors and are quite likely to be influenced by omitted variable 
bias. 
A few studies provide data and/or analyses that may shed a little light on the learning 
curve hypothesis. Fergusson et al. (2001) estimated a negative coefficient for 
cannabis use in logistic regression, suggesting that an increase in use was associated 
with a lower accident risk. The coefficient was not statistically significant. Gerberich 
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et al. (2003) found that males who reported using cannabis more than five years had 
lower accident risk than those who reported using cannabis less than five years. 
Among females, the opposite was found: the longer the use of cannabis, the higher 
the accident risk. Use of cannabis more than once per week among males was 
associated with lower risk than use of cannabis less than once per week. Again, 
however, the pattern was the opposite among females. 
Engeland et al. (2007) found a weak tendency for risk to be reduced after 14 days of 
using opioids prescribed as a painkiller, compared to the risk associated with 7 days 
of usage. Gibson et al. (2009) also found that prolonged use of opioids was 
associated with lower risk. Majdzadeh et al. (2009) found an increase in risk during 
the first few hours after consumption of opioids, then a decline. The study covered 
six hours after consumption. Romano et al. (2014) found a negative coefficient for 
use of cannabis in logistic regression, reproducing the finding of Fergusson et al. 
(2001). 
The results of these studies give, at best, a weak indication that long-term use of a 
drug may be associated with lower risk. The findings are, however, too few to 
support a claim that the negative risk curves can be explained in terms of habituation 
and increased tolerance of drugs. 
 
4.3 Selective driver recruitment 
The final hypotheses about how a negative risk curve can arise is that the high-risk 
end of the curve is associated with a selective recruitment of drivers; that the high 
risk found is the result not only, or perhaps primarily, of drug use, but of behaviour 
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which is socially deviant in many respects. Few, if any, studies present data or 
analyses that shed light on this hypothesis. Some studies, for example Gjerde et al. 
(2011, 2013), contain tables showing characteristics of cases and controls, like age, 
gender, place of residence etc. These are easily observable characteristics, and there 
are usually no dramatic differences between cases and controls with respect to these 
characteristics. 
Gjerde et al. (2011) note that “the use of illegal drugs, the abuse of psychoactive 
medicinal drugs, binge drinking of alcohol can all be related to risk taking behaviour, 
and subsequently careless or aggressive driving. This may have been a significant 
confounding factor that cannot be adjusted for in the calculations.” Indeed, a report 
prepared by the Traffic Police in Norway (Pasnin et al. 2009) found that a large share 
of drivers who were involved in fatal accidents had a criminal record. The criminal 
record included all types of offences – violence, burglary, rape, etc. – and not just 
traffic offences. Thus, in a society like Norway, where using drugs is still an offence 
and widely disapproved of by most people, those who take drugs and drive are a very 
atypical group. 
It requires extensive data collection to be able to statistically control for various 
forms of social deviancy. It is fair to say that none of the studies included in this 
paper have controlled very well for driver characteristics. It is, to be sure, not easy. In 
particular, when the groups of interest are so small as they probably are in Norway, 
one simply does not have statistical power to estimate the effects of more than a few 
driver characteristics, which, to make things even more difficult, are highly 
correlated. 
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It is therefore to a large extent unknown whether unmeasured driver characteristics 




An analyst preparing for meta-analysis will often develop funnel plots and examine 
them critically. Were one to do so for studies of the risk associated with the use of 
amphetamines, cannabis and opiates, the most logical conclusion would be not to 
perform a meta-analysis, because the estimates of risk are too widely and 
unsystematically dispersed for a weighted mean estimate of risk to make sense. 
Funnel plots, however, are not a perfectly reliable screening device to help decide 
whether to proceed with a meta-analysis or abstain from it. An untidy funnel plot 
may hide a very systematic pattern in results. For the drugs included in this paper, 
inverse risk curves were found to describe reasonably well the relationship between 
use of a drug and the risk associated with it. All these risk curves indicated that the 
less widespread the use of a drug is in normal traffic, the higher is the risk of traffic 
injury associated with it. Thus, rather than summarising the results of studies in terms 
of a single point estimate of risk, it would seem more informative to summarise the 
studies in terms of risk curves. 
However, summarising knowledge by means of curves makes sense only if the curves 
can be given a meaningful interpretation. While a risk curve may be a statistically 
more precise way of summarising knowledge than a single mean estimate of risk, the 
question that immediately comes to mind is how the risk curve arises. Unfortunately, 
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the inverse risk curves found for the illicit drugs discussed in this paper can arise in 
many ways. Ten interpretations were proposed; seven of them suggest that the 
curves are statistical artefacts. Should these interpretations be supported, it would in 
a sense create a knowledge vacuum: We found these curves, but we have no idea 
about how they arise and we are not even sure they are real. 
There are, to be sure, substantive interpretations of the curves, pointing out causal 
mechanisms that may produce them. In general, the review of studies in this paper 
found that most papers do not report the information needed to assess support for 
the substantive interpretations. These interpretations therefore remain speculative, 
although they all seem plausible. But plausibility cannot replace hard evidence. Table 
4 summarises the assessment of the various interpretations of the risk curves. 
Table 4 about here 
It is seen, that in the majority of cases, more than one interpretation is supported. 
Although there is some support for the methodological interpretations, this of course 
does not rule out that the substantive interpretations can be correct. The risk curves 
therefore show that there is deep uncertainty about the relationship between the use 
of illicit drugs and the risk of traffic injury. One cannot rely on the risk curves to 
predict the impact of policies designed to discourage the use of drugs when driving. 
Suppose, for example, that by means of targeted enforcement, one could reduce the 
share of drivers using a drug from 6 % to 3 %. Would the number of accidents be 
reduced correspondingly? Perhaps not. Perhaps the remaining 3 % of drivers would 
represent a higher risk than the original 6 %. But, then again, the remaining 3 % were 
included in the original 6 %, so perhaps there would be a net reduction of accidents 
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after all. It would, however, most likely not be a linear function of the percentage of 
drivers taking the drugs. It is pure fantasy to try to use the risk curves to predict the 
impacts of any policy intervention. 
 
6 CONCLUSIONS 
The following main conclusions can be drawn from the study presented in this 
paper: 
1. A negative risk curve has been found for amphetamines, cannabis and 
opiates, meaning that the higher the proportion of drivers in roadside surveys 
testing positive for these drugs, the lower is the estimated risk of traffic injury 
associated with them. 
2. Negative risk curves can arise in many ways. Ten sources of such curves are 
identified. 
3. In general, it cannot be ruled out that the negative risk curves found for illicit 
drugs are statistical artefacts. 
4. There is insufficient evidence to assess the support for a substantive 
interpretation of the risk curves. 
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Table 1: 
Interpretation of interaction Evaluation of interpretation Evidence for or against interpretation 
1 Statistical weighting of data points Compare curve fitted by giving all data points the same weight to 
curve fitted to data points with inverse-variance weights 
If the weighted curve is flatter than the crude curve or of a different form, the 
statistical weighting interpretation is supported 
2 Unequal variance of estimates of 
use in control group 
Compare variance of estimates of share of control group drivers 
testing positive across range of estimates 
If variance is larger when the share of control group drivers testing positive is 
low than when it is high, the unequal variance interpretation is supported 
3 Selective reporting of drug use in 
normal traffic 
Impute data points not reporting use of drug in normal traffic in a 
way that is maximally inconsistent with the pattern for data points 
reporting the use of a drug in normal traffic 
If the risk curve including both original and imputed data points differs from the 
original risk curve, failure to report the use of a drug in normal traffic may have 
influenced the risk curves 
4 Unequal adjusting for 
confounding factors 
Compare mean number of confounding variables controlled for 
between studies reporting a high share of control group drivers 
testing positive and studies reporting a low share of control group 
drivers testing positive 
If there is poorer control for confounding variables in studies reporting a low 
share of control group drivers testing positive, the unequal adjusting 
interpretation is supported 
5 Confounding by different 
estimators of risk 
Compare estimates of risk based on culpability ratio, odds ratio 
and relative risk across range of share of control group drivers 
testing positive 
If the culpability and odds ratio estimators are more common in studies 
showing a low share of control group drivers testing positive than in studies 
showing a high share of control group drivers testing positive, the bias by 
choice of estimator interpretation is supported 
6 Small sample bias in odds ratio Compare sample size serving as basis for estimating odds ratio 
across the range of share of control group drivers testing positive 
If studies finding high risk are based on smaller sample sizes than those 
finding low risk, the small sample bias interpretation is supported 
7 Publication bias Conduct a trim-and-fill analysis to test for publication bias; fit curve 
to trimmed data set 
If the curve fitted to the trimmed data set is flatter than the curve fitted to the 
complete data set, the publication bias interpretation is supported 
8 Dose-response curve Identify data points belonging to a dose-response curve and 
compare them to data points not belonging to a dose-response 
curve 
If a curve fitted to data points not belonging to a dose-response curve is flatter 
than a curve fitted to data points belonging to a dose-response curve, the 
dose-response interpretation is supported 
9 Learning curve Check if studies showing a high share of control group drivers 
testing positive provide evidence of tolerance or long-term drug 
use among these drivers more often than studies showing a low 
share of control group drivers testing positive 
If there is evidence of more tolerance or long-term drug use in studies showing 
a high share of control group drivers testing positive, the learning curve 
interpretation is supported 
10 Social deviance; selective 
recruitment 
Check if evidence of social deviance is found more often in studies 
indicating high risk than in studies indicating low risk 
If there is stronger evidence of social deviance in studies showing high risk 


























Amphetamines Fatal 10 No Power -0.740 0.194    
   Yes Inverse 1.850 0.213 Not defined Not defined Difference 
Cannabis Fatal 27 No Logarithmic -0.377 0.093    
   Yes Quadratic 0.009; -0.001 0.004; 0.000 Not defined Not defined Difference 
Cannabis Non-fatal 22 No Inverse 1.427 0.159    
   Yes Inverse 1.398 0.097 0.029 0.186 No difference 
Cannabis Property damage 14 No Quadratic -0.119; 0.003 0.078; 0.002    
   Yes Quadratic -0.109; 0.003 0.004; 0.000 -0.010; 0.000 0.078; 0.002 No difference 
Opiates Fatal 7 No Inverse 2.290 0.422    
   Yes Inverse 1.311 0.361 0.979 0.555 No difference 
Opiates Non-fatal 8 No Inverse 0.466 0.238    

















Crude estimate of risk 
 






Percentage change in 
estimate of risk 
Amphetamines Fatal Gjerde et al. 2011 26.70 20.90 4 -22 % 
Cannabis Fatal Bedard et al. 2007 1.39 1.29 7 -7 % 
Cannabis Fatal Gadegbeku et al. 2011 2.26 1.53 4 -32 % 
Cannabis Fatal Gadegbeku et al. 2011 4.54 2.84 4 -37 % 
Cannabis Fatal Gadegbeku et al. 2011 3.51 2.01 4 -43 % 
Cannabis Fatal Gjerde et al. 2013 2.40 1.90 7 -21 % 
Cannabis Fatal Poulsen et al. 2014 2.40 1.42 8 -41 % 
Cannabis Fatal Poulsen et al. 2014 1.97 0.98 8 -50 % 
Cannabis Fatal Poulsen et al. 2014 2.95 1.61 8 -45 % 
Cannabis Non-fatal Blows et al. 2005 11.40 0.80 11 -93 % 
Cannabis Non-fatal Blows et al. 2005 12.70 9.50 11 -25 % 
Cannabis Property damage Mann et al. 2010 3.28 1.84 8 -44 % 
Cannabis Property damage Compton and Berning 2015 1.25 1.00 4 -20 % 
Opiates Injury Gibson et al. 2009 1.44 0.90 8 -37 % 
















Opiates fatal injury Opiates non-fatal 
injury 
Statistical weighting Not an issue Does matter Not an issue Not an issue Not an issue Does matter 
Unequal variance of exposure Not an issue Not an issue Not an issue Not an issue Does matter Not an issue 
Selective reporting of exposure Not an issue Does matter Not an issue Not an issue Does matter Does matter 
Unequal control for confounding Not an issue Weak effect found Weak effect found Weak effect found Not an issue Strong effect found 
Choice of estimator of risk Not an issue Not an issue Cannot be tested Cannot be tested Not an issue Not an issue 
Biased estimates of risk Not an issue Not an issue Maybe a problem Not an issue Cannot be tested Not an issue 
Publication bias Not an issue Not an issue Not an issue Not an issue Does matter Does matter 
Dose-response relationship Cannot be tested Cannot be tested Is supported Is supported Cannot be tested Cannot be tested 
Learning curve Cannot be tested Cannot be tested Weak tendency Weak tendency Cannot be tested Weak tendency 
Selective driver recruitment No relevant data No relevant data No relevant data No relevant data No relevant data No relevant data 
 
